Normosmic idiopathic hypogonadotropic hypogonadism (IHH) and Kallmann syndrome are rare congenital forms of secondary hypogonadism characterized by delayed or absent sexual development.
Secondary hypogonadism is when hormone production is caused by problems in brain signaling. In these cases, also known as hypogonadotropic hypogonadism, the activity of the pituitary gland (which ...
Its growth is driven by a rising awareness of hypogonadism. The global testosterone replacement therapy (TRT) market is projected to grow by $461m by 2029 at a compound annual growth rate of 3.3%, ...
Burnett-Bowie et al. investigated the efficacy and safety of the synthetic aromatase inhibitor anastrozole to treat hypogonadism in aging men. The study enrolled 88 men (60 years or older ...
PATIENTS AND METHODS Eighteen boys (aged 13.9–17.5 years at the start of treatment)—seven with primary hypogonadism, nine with secondary hypogonadism, and two boys being treated with testosterone for ...
Obesity is associated with hypogonadism. While this association is widely accepted, the underlying mechanisms remain unclear. Furthermore, obesity is a risk factor for hypogonadism and conversely ...
Low testosterone, also known as hypogonadism, is a condition in which the body produces less than needed levels of testosterone, a sex hormone. According to studies, the prevalence of low testosterone ...
Patients with FF showed higher accumulated GC doses (16.6±18.4 vs 11.1±12.9 g, p=0.046). On multivariate analysis, hypogonadism (OR 12.38; 95% CI 1.85 to >100, p=0.01) and having received GC boluses ...
Elderly. Nursing mothers: not recommended. Testosterone replacement therapy in adult males with congenital or acquired primary hypogonadism or hypogonadotropic hypogonadism. To stimulate puberty ...
It involves administering synthetic or bioidentical testosterone to restore hormonal balance. According to 2023 report by National Library of Medicine it was reported that hypogonadism occurs in 19% ...